Patent · US Expired

Certain 1-(D-cycloproplyglycinyl)-4-piperidin-4-yl)piperazine compounds as inhibitors of the serine protease factor Xa

US7166606B2 · kind B2 · utility

0Cited by
1References
12Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 24, 2003
Grant dateJan 23, 2007
Priority date
Expiry dateOct 15, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07C2601/02
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The compounds of formula (I)in which R represents a hydrogen atom or a fluorine atom, or a pharmaceutically acceptable salt thereof are Factor Xa inhibitors useful in the treatment of thrombotic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.